Joanna Mazurek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joanna Mazurek has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Wojciech Gąska
Stefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ in Lublin, Aleja Kraśnicka 100, 20-718 Lublin, Poland
8 shared publications - Agnieszka Brzezińska
Stefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ in Lublin, Aleja Kraśnicka 100, 20-718 Lublin, Poland
7 shared publications - Barbara Madoń
Medical University of Lublin, Lublin, Poland
7 shared publications - Barbara Teresińska
Department of Forensic Medicine, Medical University of Lublin, ul. Jaczewskiego 8b, 20-090 Lublin, Poland
7 shared publications - Ignacy Rożek
Stefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ in Lublin, Aleja Kraśnicka 100, 20-718 Lublin, Poland
7 shared publications - Izabela Lekan
St. John Paul II Provincial Hospital in Siedlce, Siedlce, Poland
7 shared publications
Latest Publications
- Open Access
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 6 (3(47))
MODERN STRATEGIES FOR THE TREATMENT OF TREATMENT-RESISTANT DEPRESSION – A LITERATURE REVIEW
Treatment-resistant depression (TRD) remains a major therapeutic challenge in psychiatry, affecting a substantial proportion of individuals diagnosed with major depressive disorder and contributing significantly to the overall burden of mental illness. Despite decades of research and the availability of numerous antidepressant agents, many patients fail to achieve full remission, which underscores the urgent need for more effective interventions. This review provides a comprehensive and up-to-date analysis of both established and novel strategies for the management of TRD, encompassing pharmacological augmentation approaches, a variety of neuromodulation techniques, the clinical application of psychedelic- assisted therapies, and the development of innovative compounds currently under investigation. Particular emphasis is placed on the therapeutic potential and clinical outcomes associated with ketamine, esketamine, and psilocybin, which have emerged as promising options for patients who do not respond to conventional treatments. In addition, the review explores future directions in TRD management, including the repurposing of agents such as lurasidone, pioglitazone, and minocycline, which may offer new mechanisms of action and improved tolerability. Finally, the discussion highlights the importance of adopting a personalized, evidence-based, and multidimensional treatment approach, with the goal of improving both short-term response rates and long-term functional recovery in individuals suffering from TRD.
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 6 (3(47))
Open AccessMODERN STRATEGIES FOR THE TREATMENT OF TREATMENT-RESISTANT DEPRESSION – A LITERATURE REVIEW
Treatment-resistant depression (TRD) remains a major therapeutic challenge in psychiatry, affecting a substantial proportion of individuals diagnosed with major depressive disorder and contributing significantly to the overall burden of mental illness. Despite decades of research and the availability of numerous antidepressant agents, many patients fail to achieve full remission, which underscores the urgent need for more effective interventions. This review provides a comprehensive and up-to-date analysis of both established and novel strategies for the management of TRD, encompassing pharmacological augmentation approaches, a variety of neuromodulation techniques, the clinical application of psychedelic- assisted therapies, and the development of innovative compounds currently under investigation. Particular emphasis is placed on the therapeutic potential and clinical outcomes associated with ketamine, esketamine, and psilocybin, which have emerged as promising options for patients who do not respond to conventional treatments. In addition, the review explores future directions in TRD management, including the repurposing of agents such as lurasidone, pioglitazone, and minocycline, which may offer new mechanisms of action and improved tolerability. Finally, the discussion highlights the importance of adopting a personalized, evidence-based, and multidimensional treatment approach, with the goal of improving both short-term response rates and long-term functional recovery in individuals suffering from TRD.
- Open Access
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(47))
ADHD TREATMENT: FROM MEDICATION TO BEHAVIORAL THERAPIES- A SYSTEMATIC REVIEW
Introduction: Nowadays, ADHD is one of the most common diagnoses in the mental health field. It presents a wide spectrum of clinical presentations that affect patients’ everyday life. Variety of symptoms make each patients’ needs individual, and because of that, treatment of ADHD must be adjusted to each person separately to achieve the best possible outcome. Materials and methods: This article, based on a PubMed review of available research, examines ADHD treatment Key findings and conclusions: Options in first line medications are limited, therefore formulation technologies are one of the few methods to modify the therapy. Alternative to that, especially for patients that cannot take stimulants, are non-stimulant medications generally used in other medical fields. Additionally, psychotherapy is inherent for patients to understand their disorder, which allows them to accept it. The aim of this article is to present the basis of a complex issue, as ADHD treatment is.
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(47))
Open AccessADHD TREATMENT: FROM MEDICATION TO BEHAVIORAL THERAPIES- A SYSTEMATIC REVIEW
Introduction: Nowadays, ADHD is one of the most common diagnoses in the mental health field. It presents a wide spectrum of clinical presentations that affect patients’ everyday life. Variety of symptoms make each patients’ needs individual, and because of that, treatment of ADHD must be adjusted to each person separately to achieve the best possible outcome. Materials and methods: This article, based on a PubMed review of available research, examines ADHD treatment Key findings and conclusions: Options in first line medications are limited, therefore formulation technologies are one of the few methods to modify the therapy. Alternative to that, especially for patients that cannot take stimulants, are non-stimulant medications generally used in other medical fields. Additionally, psychotherapy is inherent for patients to understand their disorder, which allows them to accept it. The aim of this article is to present the basis of a complex issue, as ADHD treatment is.
- Open Access
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(47))
CUTANEOUS MELANOMA – DIAGNOSIS, TREATMENT, AND THE POTENTIAL IMPACT OF PHYSICAL ACTIVITY
Malignant melanoma is one of the most aggressive forms of skin cancer, with its incidence steadily increasing worldwide. Although it accounts for a minority of skin cancer cases, it is responsible for the majority of skin cancer–related deaths. This review discusses the epidemiology, clinical characteristics, and histopathological features of the main melanoma subtypes, including superficial spreading melanoma (SSM), nodular melanoma (NM), lentigo maligna melanoma (LMM), and acral lentiginous melanoma (ALM). Particular attention is given to current diagnostic strategies, ranging from the gold standard of histopathological examination to emerging non-invasive techniques such as dermoscopy, reflectance confocal microscopy (RCM), optical coherence tomography (OCT), high-frequency ultrasound (HFUS), and the novel tape stripping method. These approaches have improved early detection and the accurate assessment of tumor margins, supporting more personalized therapeutic planning. Treatment remains primarily surgical in early-stage melanoma, while advanced cases increasingly benefit from immunotherapy and targeted therapies, which have significantly improved survival outcomes. Additionally, this article explores the potential association between physical activity and melanoma risk, emphasizing that outdoor activity may increase susceptibility due to greater ultraviolet (UV) exposure. Prevention strategies, including public education and effective photoprotection, remain essential in mitigating disease burden. In conclusion, despite significant advances in diagnosis and therapy, malignant melanoma continues to pose major clinical and public health challenges, underscoring the importance of early detection, prevention, and ongoing research.
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(47))
Open AccessCUTANEOUS MELANOMA – DIAGNOSIS, TREATMENT, AND THE POTENTIAL IMPACT OF PHYSICAL ACTIVITY
Malignant melanoma is one of the most aggressive forms of skin cancer, with its incidence steadily increasing worldwide. Although it accounts for a minority of skin cancer cases, it is responsible for the majority of skin cancer–related deaths. This review discusses the epidemiology, clinical characteristics, and histopathological features of the main melanoma subtypes, including superficial spreading melanoma (SSM), nodular melanoma (NM), lentigo maligna melanoma (LMM), and acral lentiginous melanoma (ALM). Particular attention is given to current diagnostic strategies, ranging from the gold standard of histopathological examination to emerging non-invasive techniques such as dermoscopy, reflectance confocal microscopy (RCM), optical coherence tomography (OCT), high-frequency ultrasound (HFUS), and the novel tape stripping method. These approaches have improved early detection and the accurate assessment of tumor margins, supporting more personalized therapeutic planning. Treatment remains primarily surgical in early-stage melanoma, while advanced cases increasingly benefit from immunotherapy and targeted therapies, which have significantly improved survival outcomes. Additionally, this article explores the potential association between physical activity and melanoma risk, emphasizing that outdoor activity may increase susceptibility due to greater ultraviolet (UV) exposure. Prevention strategies, including public education and effective photoprotection, remain essential in mitigating disease burden. In conclusion, despite significant advances in diagnosis and therapy, malignant melanoma continues to pose major clinical and public health challenges, underscoring the importance of early detection, prevention, and ongoing research.
- Open Access
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(47))
MULTIDIMENSIONAL TREATMENT OF ENDOMETRIOSIS – THE ROLE OF NUTRITIONAL, PHYSIOTHERAPEUTIC AND PSYCHOLOGICAL INTERVENTIONS
Endometriosis is a chronic, progressive gynecological disease characterized by the presence of active endometrial tissue outside the uterine cavity. Endometriosis impacts around 10% of women in their reproductive years, often leading to persistent pain, cycle disturbances, and challenges with conception. Conventional management, which includes medication and surgery, is often insufficient due to high recurrence rates and suboptimal outcomes, prompting increased focus on complementary treatment strategies. The main aim of this work is to analyze the role of three key areas of supportive therapy: diet, physiotherapy and psychotherapy in relieving the symptoms of endometriosis and improving the quality of life of patients. This is a review-based study that analyzes scientific sources from 1997 to 2025. Analysis of current studies highlights the potential of an anti-inflammatory diet, regular pelvic-focused physiotherapy, and psychotherapy as effective complementary strategies alongside conventional treatment. An integrated therapeutic approach, taking into account the somatic and psychological needs of patients, seems to be crucial in the effective management of endometriosis.
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(47))
Open AccessMULTIDIMENSIONAL TREATMENT OF ENDOMETRIOSIS – THE ROLE OF NUTRITIONAL, PHYSIOTHERAPEUTIC AND PSYCHOLOGICAL INTERVENTIONS
Endometriosis is a chronic, progressive gynecological disease characterized by the presence of active endometrial tissue outside the uterine cavity. Endometriosis impacts around 10% of women in their reproductive years, often leading to persistent pain, cycle disturbances, and challenges with conception. Conventional management, which includes medication and surgery, is often insufficient due to high recurrence rates and suboptimal outcomes, prompting increased focus on complementary treatment strategies. The main aim of this work is to analyze the role of three key areas of supportive therapy: diet, physiotherapy and psychotherapy in relieving the symptoms of endometriosis and improving the quality of life of patients. This is a review-based study that analyzes scientific sources from 1997 to 2025. Analysis of current studies highlights the potential of an anti-inflammatory diet, regular pelvic-focused physiotherapy, and psychotherapy as effective complementary strategies alongside conventional treatment. An integrated therapeutic approach, taking into account the somatic and psychological needs of patients, seems to be crucial in the effective management of endometriosis.
- Open Access
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(47))
DEMENTIA – DIFFERENTIATION AND THE SIGNIFICANCE OF EARLY DIAGNOSIS
Dementias are a complex group of neurodegenerative diseases characterized by a progressive decline in cognitive functions, significantly affecting patients' daily lives. Differentiating between types of dementia, such as Alzheimer’s disease, vascular dementia, Lewy body dementia, and frontotemporal dementia, is essential for appropriate therapy planning, disease prognosis, and optimizing care. Diagnosis is based on a comprehensive assessment of clinical symptoms, neuroimaging studies, and analysis of fluid biomarkers. Clinical symptoms, such as memory impairment, attention deficits, executive dysfunction, and behavioral changes, are the basis of diagnosis; however, differentiation requires support from brain imaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET), which allow the identification of characteristic structural and metabolic changes. Biomarkers, particularly tau and beta-amyloid proteins measured in cerebrospinal fluid and serum, are important tools for confirming the diagnosis and monitoring disease progression. Early diagnosis of dementia is crucial for the effectiveness of therapy and improving patients’ quality of life. It enables the implementation of interventions that slow disease progression and provides appropriate psychosocial support for patients and their families. In recent years, artificial intelligence (AI) has played an increasing role in the diagnosis of dementia. Advanced algorithms analyzing clinical, neuroimaging, and biomarker data support more accurate and faster differentiation of dementia types and help identify at-risk individuals at early disease stages. The implementation of AI in clinical practice opens new opportunities for personalized treatment and patient care.
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(47))
Open AccessDEMENTIA – DIFFERENTIATION AND THE SIGNIFICANCE OF EARLY DIAGNOSIS
Dementias are a complex group of neurodegenerative diseases characterized by a progressive decline in cognitive functions, significantly affecting patients' daily lives. Differentiating between types of dementia, such as Alzheimer’s disease, vascular dementia, Lewy body dementia, and frontotemporal dementia, is essential for appropriate therapy planning, disease prognosis, and optimizing care. Diagnosis is based on a comprehensive assessment of clinical symptoms, neuroimaging studies, and analysis of fluid biomarkers. Clinical symptoms, such as memory impairment, attention deficits, executive dysfunction, and behavioral changes, are the basis of diagnosis; however, differentiation requires support from brain imaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET), which allow the identification of characteristic structural and metabolic changes. Biomarkers, particularly tau and beta-amyloid proteins measured in cerebrospinal fluid and serum, are important tools for confirming the diagnosis and monitoring disease progression. Early diagnosis of dementia is crucial for the effectiveness of therapy and improving patients’ quality of life. It enables the implementation of interventions that slow disease progression and provides appropriate psychosocial support for patients and their families. In recent years, artificial intelligence (AI) has played an increasing role in the diagnosis of dementia. Advanced algorithms analyzing clinical, neuroimaging, and biomarker data support more accurate and faster differentiation of dementia types and help identify at-risk individuals at early disease stages. The implementation of AI in clinical practice opens new opportunities for personalized treatment and patient care.
- Open Access
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(47))
THE CORRELATION BETWEEN SLEEP DISORDERS AND ULCERATIVE COLITIS AND OTHER AUTOIMMUNE DISEASES: A SCIENTIFIC REVIEW
Ulcerative colitis (UC), a chronic inflammatory bowel disease (IBD), is an autoimmune disease and is increasingly recognised for its bidirectional relationship with sleep disorders. Emerging evidence suggests that sleep disturbances not only exacerbate UC symptoms but may also influence disease activity and relapse rates. Sleep deprivation is increasingly recognized as a significant factor influencing the pathogenesis and progression of autoimmune diseases. This review also synthesizes current evidence on the bidirectional relationship between sleep disturbances and autoimmune conditions, focusing on underlying mechanisms, clinical implications, and potential therapeutic strategies.
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(47))
Open AccessTHE CORRELATION BETWEEN SLEEP DISORDERS AND ULCERATIVE COLITIS AND OTHER AUTOIMMUNE DISEASES: A SCIENTIFIC REVIEW
Ulcerative colitis (UC), a chronic inflammatory bowel disease (IBD), is an autoimmune disease and is increasingly recognised for its bidirectional relationship with sleep disorders. Emerging evidence suggests that sleep disturbances not only exacerbate UC symptoms but may also influence disease activity and relapse rates. Sleep deprivation is increasingly recognized as a significant factor influencing the pathogenesis and progression of autoimmune diseases. This review also synthesizes current evidence on the bidirectional relationship between sleep disturbances and autoimmune conditions, focusing on underlying mechanisms, clinical implications, and potential therapeutic strategies.
- Open Access
- 24 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(47))
AGENESIS OF THE INTERNAL CAROTID ARTERY - COLLATERAL VASCULARIZATION AND SYMPTOMATIC MANIFESTATIONS
Introduction and objective: Internal carotid artery agenesis is a rare anatomical anomaly involving the absence of the internal carotid artery. It is a congenital developmental defect that can present with varying symptoms depending on whether it is unilateral or bilateral. The aim of this article is to summarize the diversity and prevalence of symptoms associated with unilateral or bilateral agenesis of the internal carotid artery. Methodology: In the literature review, scientific works related to internal carotid artery agenesis were utilized, including 26 studies addressing the described variability, which collectively encompass 52 cases of patients with internal carotid artery agenesis. After a thorough analysis of the cited literature, conclusions were drawn regarding the frequency and relationships between unilateral and bilateral absence of the ICA. Discussion: Agenesis of the internal carotid artery is a rare anomaly; however, its detection is crucial in the diagnosis of cerebrovascular disorders. Among symptomatic patients with internal carotid artery agenesis, intracranial aneurysms leading to subarachnoid hemorrhages were frequently observed. Additionally, collateral pathways replacing its blood flow, such as perineural anastomoses, and alterations in the normal course of other vessels in the neck and head region were also noted. Conclusions: Agenesis of the ICA occurs in 0.01% of cases and is additionally associated with the absence of the carotid canal, through which the artery typically traverses. It is more commonly seen as left-sided agenesis of the ICA, with bilateral agenesis occurring in less than 10% of cases. 25% of cases of internal carotid artery agenesis are associated with intracranial aneurysms. The majority of symptomatic patients are between 35 and 65 years of age. Patients with internal carotid artery agenesis most frequently exhibit neurological disorders as well as nonspecific symptoms such as headaches and nausea.
- 24 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(47))
Open AccessAGENESIS OF THE INTERNAL CAROTID ARTERY - COLLATERAL VASCULARIZATION AND SYMPTOMATIC MANIFESTATIONS
Introduction and objective: Internal carotid artery agenesis is a rare anatomical anomaly involving the absence of the internal carotid artery. It is a congenital developmental defect that can present with varying symptoms depending on whether it is unilateral or bilateral. The aim of this article is to summarize the diversity and prevalence of symptoms associated with unilateral or bilateral agenesis of the internal carotid artery. Methodology: In the literature review, scientific works related to internal carotid artery agenesis were utilized, including 26 studies addressing the described variability, which collectively encompass 52 cases of patients with internal carotid artery agenesis. After a thorough analysis of the cited literature, conclusions were drawn regarding the frequency and relationships between unilateral and bilateral absence of the ICA. Discussion: Agenesis of the internal carotid artery is a rare anomaly; however, its detection is crucial in the diagnosis of cerebrovascular disorders. Among symptomatic patients with internal carotid artery agenesis, intracranial aneurysms leading to subarachnoid hemorrhages were frequently observed. Additionally, collateral pathways replacing its blood flow, such as perineural anastomoses, and alterations in the normal course of other vessels in the neck and head region were also noted. Conclusions: Agenesis of the ICA occurs in 0.01% of cases and is additionally associated with the absence of the carotid canal, through which the artery typically traverses. It is more commonly seen as left-sided agenesis of the ICA, with bilateral agenesis occurring in less than 10% of cases. 25% of cases of internal carotid artery agenesis are associated with intracranial aneurysms. The majority of symptomatic patients are between 35 and 65 years of age. Patients with internal carotid artery agenesis most frequently exhibit neurological disorders as well as nonspecific symptoms such as headaches and nausea.
- Open Access
- 22 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(47))
OBESITY MANAGEMENT - A COMPARATIVE REVIEW OF THE EFFICACY AND SAFETY OF BARIATRIC SURGERY AND TIRZEPATIDE THERAPY
Objective: Obesity is a major global health burden associated with increased morbidity, mortality, and healthcare costs. This review aimed to compare the efficacy and safety of tirzepatide, a novel dual GLP-1/GIP receptor agonist, with bariatric surgery, focusing on their roles in weight reduction, metabolic improvement, and long-term risk–benefit profiles. Methods: A comprehensive literature search was performed using PubMed and official regulatory and professional society sources (FDA, EMA, MHRA, IFSO). Search terms included “obesity,” “bariatric surgery,” “tirzepatide,” and “GLP-1 and GIP receptor agonist.” Only peer-reviewed English-language studies with high levels of evidence, including randomized controlled trials, meta-analyses, systematic reviews, and clinical guidelines, were included. Key Findings: Bariatric surgery, particularly Roux-en-Y gastric bypass and sleeve gastrectomy, was associated with the most profound and durable weight loss (25–28% short-term; 18–25% long-term), alongside significant remission of type 2 diabetes, hypertension, and dyslipidemia. However, its invasive nature and risk of perioperative and late complications necessitate multidisciplinary follow-up. Tirzepatide demonstrated dose-dependent reductions in body weight (~10–20%), improved glycemic control, lipid profiles, and blood pressure, and enhanced quality of life. Its safety profile was favorable, predominantly gastrointestinal, but long-term data remain limited. Conclusions: Bariatric surgery remains the gold standard for severe obesity due to its magnitude and sustainability of benefits. Tirzepatide represents a promising, less-invasive pharmacological option, particularly for patients with moderate obesity or contraindications to surgery. Further research is required to establish its long-term efficacy and safety profile.
- 22 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(47))
Open AccessOBESITY MANAGEMENT - A COMPARATIVE REVIEW OF THE EFFICACY AND SAFETY OF BARIATRIC SURGERY AND TIRZEPATIDE THERAPY
Objective: Obesity is a major global health burden associated with increased morbidity, mortality, and healthcare costs. This review aimed to compare the efficacy and safety of tirzepatide, a novel dual GLP-1/GIP receptor agonist, with bariatric surgery, focusing on their roles in weight reduction, metabolic improvement, and long-term risk–benefit profiles. Methods: A comprehensive literature search was performed using PubMed and official regulatory and professional society sources (FDA, EMA, MHRA, IFSO). Search terms included “obesity,” “bariatric surgery,” “tirzepatide,” and “GLP-1 and GIP receptor agonist.” Only peer-reviewed English-language studies with high levels of evidence, including randomized controlled trials, meta-analyses, systematic reviews, and clinical guidelines, were included. Key Findings: Bariatric surgery, particularly Roux-en-Y gastric bypass and sleeve gastrectomy, was associated with the most profound and durable weight loss (25–28% short-term; 18–25% long-term), alongside significant remission of type 2 diabetes, hypertension, and dyslipidemia. However, its invasive nature and risk of perioperative and late complications necessitate multidisciplinary follow-up. Tirzepatide demonstrated dose-dependent reductions in body weight (~10–20%), improved glycemic control, lipid profiles, and blood pressure, and enhanced quality of life. Its safety profile was favorable, predominantly gastrointestinal, but long-term data remain limited. Conclusions: Bariatric surgery remains the gold standard for severe obesity due to its magnitude and sustainability of benefits. Tirzepatide represents a promising, less-invasive pharmacological option, particularly for patients with moderate obesity or contraindications to surgery. Further research is required to establish its long-term efficacy and safety profile.
- Open Access
- 3 October 2024
- Published by Warszawski Uniwersytet Medyczny in Prospects in Pharmaceutical Sciences
- Vol. 22 (4) , 7-15
Review of the effects of sodium butyrate on obesity, inflammatory bowel disease, pregnancy and colorectal cancer
Introduction and Purpose: Short-chain fatty acids (SCFAs), including butyric acid, acetic acid and propionic acid, are naturally produced in the large intestine by bacterial fermentation of insoluble carbohydrates and oligosaccharides. Butyric acid, which is the main source of energy for colon cells, has regenerative, cytoprotective and anti-inflammatory effects. Its physiological importance lies in maintaining the integrity and function of the intestinal epithelium, which protects the body against pathogens and oxidative stress. SCFA deficiencies resulting from low dietary fiber supply can lead to intestinal disorders. Supplementation with sodium butyrate, particularly using micro-encapsulation technology, enables efficient delivery of butyric acid to the gut, which may be beneficial in the treatment of inflammatory bowel disease and in the prevention of obesity and insulin resistance. Sodium butyrate (NaB) also has promising potential in the treatment of colorectal cancer (CRC), inducing apoptosis of cancer cells, increasing sensitivity to radiotherapy and chemotherapy and protecting healthy cells. SCFAs, especially butyrate, play a key role in reproductive medicine, oncology and gastroenterology, contributing to the maintenance of health and being potential therapeutic targets. The aim of this paper is to review the available literature on this topic. Material and methods: The review was based on articles obtained from PubMed scientific database published from 2014-2024, using the following keywords: sodium butyrate, obesity, pregnancy, inflammatory bowel disease, colorectal cancer, SCFA. Conclusions: Studies confirm the beneficial effects of sodium butyrate on metabolism, intestinal integrity and reduction of inflammation, opening up new possibilities in the treatment of metabolic disorders and intestinal diseases. However, further clinical studies conducted on humans are still needed, as most of the work to date has been conducted on mice and/or rats.
- 3 October 2024
- Published by Warszawski Uniwersytet Medyczny in Prospects in Pharmaceutical Sciences
- Vol. 22 (4) , 7-15
Open AccessReview of the effects of sodium butyrate on obesity, inflammatory bowel disease, pregnancy and colorectal cancer
Introduction and Purpose: Short-chain fatty acids (SCFAs), including butyric acid, acetic acid and propionic acid, are naturally produced in the large intestine by bacterial fermentation of insoluble carbohydrates and oligosaccharides. Butyric acid, which is the main source of energy for colon cells, has regenerative, cytoprotective and anti-inflammatory effects. Its physiological importance lies in maintaining the integrity and function of the intestinal epithelium, which protects the body against pathogens and oxidative stress. SCFA deficiencies resulting from low dietary fiber supply can lead to intestinal disorders. Supplementation with sodium butyrate, particularly using micro-encapsulation technology, enables efficient delivery of butyric acid to the gut, which may be beneficial in the treatment of inflammatory bowel disease and in the prevention of obesity and insulin resistance. Sodium butyrate (NaB) also has promising potential in the treatment of colorectal cancer (CRC), inducing apoptosis of cancer cells, increasing sensitivity to radiotherapy and chemotherapy and protecting healthy cells. SCFAs, especially butyrate, play a key role in reproductive medicine, oncology and gastroenterology, contributing to the maintenance of health and being potential therapeutic targets. The aim of this paper is to review the available literature on this topic. Material and methods: The review was based on articles obtained from PubMed scientific database published from 2014-2024, using the following keywords: sodium butyrate, obesity, pregnancy, inflammatory bowel disease, colorectal cancer, SCFA. Conclusions: Studies confirm the beneficial effects of sodium butyrate on metabolism, intestinal integrity and reduction of inflammation, opening up new possibilities in the treatment of metabolic disorders and intestinal diseases. However, further clinical studies conducted on humans are still needed, as most of the work to date has been conducted on mice and/or rats.
- Open Access
- 12 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 67, 55044
Intermittent fasting - a diet to fight type 2 diabetes and obesity - current state of knowledge
Obesity is a chronic disease that requires diagnosis and treatment. Excess body fat and metabolic disorders, resulting from the disease, are associated with the risk of numerous complications. Among the most widespread are type 2 diabetes, hypertension, dyslipidemia, atherosclerosis, non-alcoholic fatty liver disease and sleep apnea syndrome. Weight reduction significantly improves prognosis, and can mitigate or even reverse complications. A dietary method gaining popularity recently is intermittent fasting. It involves alternating periods of eating and fasting according to a fixed time schedule. There are different types of diet, differing in the length of the fasting period. Intermittent fasting affects the human body by regulating the diurnal rhythm, inducing metabolic switching, that is switching from using glucose as an energy source to lipid oxidation, and by modulating the composition of the gut microbiota. The effects of the diet, proven in clinical trials, include weight loss, improved glucose tolerance, lowered hemoglobin A1c and insulin levels, and improved tissue sensitivity to insulin. However, there is no evidence supporting the superiority of intermittent fasting over continuous calorie restriction. Intermittent fasting also carries a risk of adverse effects, the most serious of which are hypoglycemic episodes. These occur especially in people with type 2 diabetes and taking diabetes medications. Although intermittent fasting appears to be a promising strategy in the fight against obesity and type 2 diabetes, further research is needed to evaluate its long-term effects on the human body.
- 12 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 67, 55044
Open AccessIntermittent fasting - a diet to fight type 2 diabetes and obesity - current state of knowledge
Obesity is a chronic disease that requires diagnosis and treatment. Excess body fat and metabolic disorders, resulting from the disease, are associated with the risk of numerous complications. Among the most widespread are type 2 diabetes, hypertension, dyslipidemia, atherosclerosis, non-alcoholic fatty liver disease and sleep apnea syndrome. Weight reduction significantly improves prognosis, and can mitigate or even reverse complications. A dietary method gaining popularity recently is intermittent fasting. It involves alternating periods of eating and fasting according to a fixed time schedule. There are different types of diet, differing in the length of the fasting period. Intermittent fasting affects the human body by regulating the diurnal rhythm, inducing metabolic switching, that is switching from using glucose as an energy source to lipid oxidation, and by modulating the composition of the gut microbiota. The effects of the diet, proven in clinical trials, include weight loss, improved glucose tolerance, lowered hemoglobin A1c and insulin levels, and improved tissue sensitivity to insulin. However, there is no evidence supporting the superiority of intermittent fasting over continuous calorie restriction. Intermittent fasting also carries a risk of adverse effects, the most serious of which are hypoglycemic episodes. These occur especially in people with type 2 diabetes and taking diabetes medications. Although intermittent fasting appears to be a promising strategy in the fight against obesity and type 2 diabetes, further research is needed to evaluate its long-term effects on the human body.